Courses List

0
No products in the cart.
← Literature Database

Predictors of success following extracorporeal shock-wave lithotripsy in a contemporary cohort.

Mohit Bajaj, Russell Smith, Michael Rice, Kamran Zargar-Shoshtari

Urology annals · 2021 · Vol. 13 · Issue 3 · 282-287

PMID: 34421266 DOI: 10.4103/UA.UA_155_19

Academy Summary

Bajaj and colleagues retrospectively evaluated outcomes from a dedicated high-volume SWL service to determine which patient, stone, and treatment characteristics predicted clinical success.

The study included 421 patients with complete follow-up who underwent elective SWL for upper urinary tract stones. Stones were located in the renal calyces, renal pelvis, or proximal ureter.

Treatment success was defined as complete fragmentation with either no residual stone or residual fragments measuring 4 mm or less on imaging approximately six weeks after treatment.

Overall treatment success was 72.2%.

Several variables were examined, including stone size, stone location, Hounsfield units, skin-to-stone distance, ureteric stenting, number of shock waves, and maximum treatment intensity.

After multivariable analysis, only two factors independently predicted treatment outcome:

Stone size <10 mm

and

Skin-to-stone distance <15 cm

Stones smaller than 10 mm were approximately 3.4 times more likely to achieve successful treatment than larger stones.

Patients with an SSD greater than 15 cm had a substantially reduced likelihood of successful SWL compared with those with shorter treatment distances.

The study therefore supports incorporating both stone burden and treatment-path distance into routine SWL assessment.

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in
Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.